Robert Lenk
Director/Board Member at PLUS THERAPEUTICS, INC.
Net worth: 48 829 $ as of 2024-04-29
Robert Lenk active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | Director/Board Member | 2020-02-29 | - |
| Independent Dir/Board Member | 2020-02-29 | - | |
Houston Partners
 Houston Partners Investment ManagersFinance Houston Partners identifies regional and national investment opportunities and develops into nationally and internationally recognized public companies. It invests in early-stage and expanding companies, and focuses on the environment, technology, and health sciences. The company was founded in 1986 and is headquartered in Houston, TX. | Corporate Officer/Principal | - | - |
| Lenk Pharmaceuticals, LLC | President | 2015-12-31 | - |
POP Biotechnologies, Inc.
 POP Biotechnologies, Inc. BiotechnologyHealth Technology POP Biotechnologies, Inc. is a biotechnology company. The private company is based in Buffalo, NY. The company was founded in 2015 by Jonathan Lovell, Jonathan Smyth, Kevin Carter. | Director/Board Member | - | - |
Career history of Robert Lenk
Former positions of Robert Lenk
| Companies | Position | Start | End |
|---|---|---|---|
| MediVector, Inc. | Chief Tech/Sci/R&D Officer | - | 2015-12-31 |
| LUNA INNOVATIONS INCORPORATED | Corporate Officer/Principal | 2003-12-31 | 2010-04-14 |
| Therapeutics 2000, Inc. | Chief Executive Officer | 1994-12-31 | 2003-08-31 |
| President | 1994-12-31 | 2003-08-31 | |
| Argus Pharmaceuticals, Inc. | Chief Tech/Sci/R&D Officer | 1988-12-31 | - |
| Founder | 1988-12-31 | - | |
The Liposome Co., Inc.
 The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Founder | 1980-12-31 | - |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Robert Lenk
| Massachusetts Institute of Technology | Doctorate Degree |
Statistics
International
| United States | 12 |
Operational
| President | 3 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
Sectoral
| Health Technology | 5 |
| Finance | 3 |
| Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| LUNA INNOVATIONS INCORPORATED | Electronic Technology |
| PLUS THERAPEUTICS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Health Technology |
| Argus Pharmaceuticals, Inc. | Health Technology |
Houston Partners
Houston Partners Investment ManagersFinance Houston Partners identifies regional and national investment opportunities and develops into nationally and internationally recognized public companies. It invests in early-stage and expanding companies, and focuses on the environment, technology, and health sciences. The company was founded in 1986 and is headquartered in Houston, TX. | Finance |
| MediVector, Inc. | |
| OncoVector, Inc. | |
| Therapeutics 2000, Inc. | |
| Lenk Pharmaceuticals, LLC | |
POP Biotechnologies, Inc.
POP Biotechnologies, Inc. BiotechnologyHealth Technology POP Biotechnologies, Inc. is a biotechnology company. The private company is based in Buffalo, NY. The company was founded in 2015 by Jonathan Lovell, Jonathan Smyth, Kevin Carter. | Health Technology |
- Stock Market
- Insiders
- Robert Lenk
- Experience